Nordic Pharma Lab ApS: Financial statements 2022
CVR: 39161672
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Nordic Pharma Lab ApS (CVR 39161672) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -24,146 and a net result of DKK -33,327 compared with DKK -283,024 the year before. Equity in the 2022 report amounted to DKK -259,635.
- Gross Profit
- DKK -24,146
- Profit/Loss
- DKK -33,327
- Equity
- DKK -259,635
- Total Assets
- DKK 7,776
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -24 t. | -33 t. | -260 t. | - |
| 2021 | - | -106 t. | -283 t. | -226 t. | - |
| 2020 | 1 | -41 t. | -20 t. | 57 t. | - |
| 2019 | - | -12 t. | -12 t. | 77 t. | - |
| 2018 | - | -11 t. | -11 t. | 89 t. | - |
Official annual report
Keep an eye on Nordic Pharma Lab ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of July 13, 2022, FINANSMANAGEMENT ApS is registered as an owner of Nordic Pharma Lab ApS with an ownership share of 50%.
Nordic Pharma Lab ApS has published its annual report for 2021. Gross profit came to DKK -106,160, and the net result was DKK -283,024.
About Nordic Pharma Lab ApS
Nordic Pharma Lab ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS STM nr. 6145. The management consists of Torsten Bjørn. The company's owners include TT 1919 ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,093 and a net result of DKK -110,916 compared with DKK -30,573 the year before. Equity in the 2025 report amounted to DKK -429,426.